0 Comments
0 Shares
1K Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Janus Kinases (JAKs) Inhibitor Drugs Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032 Driven by Rising Prevalence of Autoimmune Disorders and Advancements in Targeted TherapiesAccording to the latest report published by Data Bridge Market Research, the Janus Kinases (JAKs) Inhibitor Drugs Market Data Bridge Market Research analyses that the Janus kinases (JAKs) inhibitor drugs market, which is USD 2.45 billion in 2022, is expected to reach USD 5.11 billion by 2030, at a CAGR of 9.6% during the forecast period 2023 to 2030. This Janus Kinases (JAKs)...0 Comments 0 Shares 790 Views 0 Reviews
-
Autoimmune Gastrointestinal Dysmotility Market Outlook with Rare Diseases, Diagnosis Challenges, and Treatment AdvancesExecutive Summary Autoimmune Gastrointestinal Dysmotility Market: Growth Trends and Share Breakdown CAGR Value The global autoimmune gastrointestinal dysmotility market size was valued at USD 39.45 billion in 2024 and is expected to reach USD 155.47 billion by 2032, at a CAGR of 18.70% during the forecast period Autoimmune Gastrointestinal Dysmotility Market research report is a verified...0 Comments 0 Shares 3K Views 0 Reviews
-
How the Ustekinumab Market Is Redefining Biologic Therapies for Autoimmune Diseases?Executive Summary Ustekinumab Market Opportunities by Size and Share CAGR Value The global ustekinumab market size was valued at USD 12.07 billion in 2024 and is expected to reach USD 19.09 billion by 2032, at a CAGR of 5.90% during the forecast period Ustekinumab Market research report is a verified and consistent source of information that puts forth a telescopic view of the...0 Comments 0 Shares 3K Views 0 Reviews